No Picture
News

Halozyme Announces Janssen’s Receipt Of CHMP Positive Opinion For DARZALEX® Subcutaneous Formulation Utilizing Halozyme’s ENHANZE® Technology For Patients With Multiple Myeloma

– Subcutaneous formulation can be administered in approximately five minutes, compared to multi-hour intravenous infusions –

SAN DIEGO, April 30, 2020 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Janssen-Cilag Inte… […]

No Picture
News

Viking Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

Conference call scheduled for 4:30 p.m. ET today- Enrollment Continues in Phase 2b VOYAGE Study of VK2809 in NASH- New Data from VK2809 Phase 2 NAFLD Trial to be Highlighted at EASL- IND Filing for VK0214 in X-ALD on Track for Mid-Year- Balance Sheet R… […]

No Picture
News

Viking Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

Conference call scheduled for 4:30 p.m. ET today- Enrollment Continues in Phase 2b VOYAGE Study of VK2809 in NASH- New Data from VK2809 Phase 2 NAFLD Trial to be Highlighted at EASL- IND Filing for VK0214 in X-ALD on Track for Mid-Year- Balance Sheet R… […]

No Picture
News

Viking Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

Conference call scheduled for 4:30 p.m. ET today- Enrollment Continues in Phase 2b VOYAGE Study of VK2809 in NASH- New Data from VK2809 Phase 2 NAFLD Trial to be Highlighted at EASL- IND Filing for VK0214 in X-ALD on Track for Mid-Year- Balance Sheet R… […]

No Picture
News

Progenity Strengthens Information Technology Infrastructure with Appointment of Troy Seelye as CIO

SAN DIEGO–(BUSINESS WIRE)–Progenity, a biotechnology company with an established track record of success in developing and commercializing molecular testing products, today announced the appointment of Troy Seelye as Chief Information Officer (CIO). … […]

No Picture
News

CalciMedica Expands Clinical Study to Assess CM4620-IE in Patients with Critical COVID-19 Pneumonia on High-Flow Oxygen Therapy

LA JOLLA, Calif., April 30, 2020 (GLOBE NEWSWIRE) — CalciMedica Inc. (?CalciMedica? or the ?Company), a clinical-stage biotechnology company targeting calcium release-activated calcium (CRAC) channels for the treatment of acute and severe inflammato… […]

No Picture
News

Amplyx Pharmaceuticals to Participate in Antifungal Panel at Maxim Group’s Infectious Disease Virtual Conference: The Renaissance of the Anti-infective Sector

SAN DIEGO, April 29, 2020 /PRNewswire/ — Amplyx Pharmaceuticals, a clinical stage biotech company developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems, today announced?that Ciara… […]

No Picture
News

Having sold its corporate self, Tocagen auctions off scientific platform to San Diego biotech

With the dermatitis specialists at Forte Biosciences now inhabiting Tocagen?s corporate skeleton, a small San Diego biotech has won rights to its scientific platform.
Denovo Biopharma, a biotech based in San Diego and backed largely by investors in Chi… […]

No Picture
News

Third Rock-backed startup’s blood test can sniff out cancer in patients with no history of disease

The myriad of liquid biopsy companies working on blood tests for early cancer detection have been conducting retrospective studies, looking at how effective and sensitive their technology is in spotting cancer in patients that have already been diagnos… […]

No Picture
News

Evofem Biosciences to Report First Quarter 2020 Results and Provide Corporate Update on Wednesday, May 6, 2020

— Conference Call Scheduled for 11:00 a.m. ET —- Key U.S. Regulatory Milestones Remain on Track, Including May 25, 2020 PDUFA Date —

SAN DIEGO, April 28, 2020 /PRNewswire/ –?Evofem Biosciences, Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceut… […]

No Picture
News

Decipher Identifies a Molecular Subtype Most Likely to Benefit from Neoadjuvant KEYTRUDA Immunotherapy in Bladder Cancer Patients

SAN DIEGO, April 28, 2020 /PRNewswire/ –?Decipher Biosciences, a commercial-stage precision oncology company?committed to improving patient care, initially focused on urologic cancers, announced today that patients with the molecular subtype Basal … […]

No Picture
News

Sweetwater Private Equity recognizes Adaptive Biotechnologies Corp. and its CEO Chad Robins for leadership during COVID-19 crisis

SAN DIEGO, April 28, 2020 /PRNewswire/ –?Sweetwater Investment Management (“Sweetwater” or “Sweetwater Private Equity” (dba)) announced during their recent annual investor meeting the selection of Chad Robins, CEO of Adaptive Biotechnologies Corp. … […]